Loading data for SANA — first visit, this takes a few seconds.

アラート

Sana Biotechnology Inc. (SANA)

NasdaqGS: SANA · リアルタイム株価 · USD

3.93

-0.16 (-3.91%)

終値時点： Aug 28, 2026, 8:00 PM

3.95

+0.51%

時間外: 7:46 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

-3.91% (1D)

データがありません

買気配	3.93
時価総額	1.18B
売上高（TTM）	n/a
純利益（TTM）	-211.82M
	2.10
	-0.72
	n/a
	-7.08
PBR（TTM）	8.89
PSR（TTM）	n/a
決算発表日	Nov 5, 2026

売気配	5.08
出来高	2,142,807
平均出来高（20日）	3,121,679
始値	4.05
前日終値	4.09
当日レンジ	3.89 - 4.12
52週レンジ	2.61 - 6.55
アナリスト	n/a
目標株価	n/a
配当	n/a
権利落ち日	n/a

SANAについて

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical t...

[続きを読む]

業種 Biotechnology

セクター Healthcare

IPO日 Feb 4, 2021

従業員数 142

上場取引所 NasdaqGS

ティッカー SANA

ウェブサイト https://www.sana.com

企業情報の全文

業績

2025年のSana Biotechnologyの売上高は0で、前年の0からundefined%の増加でした。利益は-244.17Mで、-8.47%の減少でした。

財務諸表

決算サプライズ

Sana BiotechnologyはAug 10, 2026に四半期決算を発表しました：

売上高は $0 で、予想を下回りました $0, うち NaN% の前年比増加にあたります.
EPSは -0.13 で、予想を下回りました -0.01, うち 18.75% の前年比増加にあたります.

次回決算発表

Sana Biotechnology Inc.の決算発表予定日は Nov 5, 2026, 取引時間中の予定です。
アナリストの売上高予想は ... アップグレード

ニュース

1か月前 · Zacks

3 Promising Genomics Stocks to Add to Your Portfolio in 2026

Genomics is reshaping healthcare, and these three stocks - MYGN, SANA and WVE - stand out as rapid advances in personalized medicine and synthetic biology continue to transform the industry.

1か月前 · Simply Wall St.

Sana Biotechnology (SANA) Publishes 14 Month Diabetes Cell Therapy Results In NEJM

Sana Biotechnology (NasdaqGS:SANA) reported long term follow up data from an investigator sponsored study of its HIP modified islet cell therapy for type 1 diabetes. Results published in The New Engla...

1か月前 · Zacks

Sana (SANA) Upgraded to Buy: Here's What You Should Know

Sana (SANA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

2か月前 · Euronews

‘I worry deeply about bioterrorism’: Is Europe sufficiently prepared for another pandemic?

Internationally renowned for their life-saving Covid vaccine, what is Moderna doing now? Their CEO joins us in the studio to discuss bioterrorism, pandemic preparedness and cancer treatment.View on eu...

4か月前 · Insider Monkey

Sana Biotech (SANA), Mayo Clinic Partner to Advance Cell Therapy for Type 1 Diabetes

Sana Biotechnology (NASDAQ:SANA) is one of the small cap stocks with the highest upside potential. On April 13, Sana Biotechnology and Mayo Clinic entered into a collaboration to accelerate the develo...

2ページ中1ページ

Sana Biotechnology Inc. (SANA)